Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
about
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsStructural mechanism of trimeric HIV-1 envelope glycoprotein activationImmunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesDelayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsAccess of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Structural definition of a conserved neutralization epitope on HIV-1 gp120Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designCellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionThe HIV glycan shield as a target for broadly neutralizing antibodiesRecent strategies targeting HIV glycans in vaccine designStructural insights on the role of antibodies in HIV-1 vaccine and therapyHIV-1 neutralizing antibodies: understanding nature's pathwaysAntibodies in HIV-1 vaccine development and therapyMicrobicides: a new hope for HIV preventionCatching HIV 'in the act' with 3D electron microscopyAntigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsAdditive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodiesEngineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectorsAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesMutations that destabilize the gp41 core are determinants for stabilizing the simian immunodeficiency virus-CPmac envelope glycoprotein complexStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsCrystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 EnvA Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing AntibodiesStructural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 InteractionStructure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodiesFocused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep SequencingBroad and potent neutralization of HIV-1 by a gp41-specific human antibodyComputation-guided backbone grafting of a discontinuous motif onto a protein scaffoldHepatitis C Virus E2 Envelope Glycoprotein Core StructureStructural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory AntibodiesPatterns of HIV/SIV Prevention and Control by Passive Antibody ImmunizationReverse vaccinology 2.0: Human immunology instructs vaccine antigen design
P2860
Q21090521-2E0C990E-2C1E-4ADC-9014-5572B41A2CA2Q21131394-32E8DE6B-6EA7-4980-AA9C-1F8EDB3E9BA5Q24531479-DEBAEDBD-D762-4CC2-80FD-D4435F7D1465Q24561905-97D65CFC-5994-4A12-83E8-41720D99971CQ24612811-7EC9E424-B8C5-4A4B-891D-845E24DCC0F7Q24635002-079DE4B2-AFAC-43FD-BF28-FEE7119B4823Q24645530-DCF28D85-A530-4AD3-850C-B3E097E0F4FCQ24655948-5B8586AD-EAED-4F05-BBC8-DE10344FDE1AQ24679395-E14F610B-F700-4475-B00B-8F156AD1358CQ24806134-8AEAFC5D-9296-4593-BC84-45B4AFC39948Q26775082-AEAC4DC2-78BC-45EF-A170-C9A3EA8BA888Q26786540-F0792086-734C-42A5-9C43-808DA00F9112Q26823603-8C30C16F-E76D-40A3-A73D-663B049DEB23Q26829461-DE44AA8C-BF97-4A78-A8F3-FEDF21349C1AQ27000480-86761363-CDF3-4138-AB9E-9B945CF041A1Q27011574-9929A501-FD52-4AF3-B4F7-28E1F738C8BBQ27022779-6F7690AA-7EE3-4895-A2A3-2286DD1C895EQ27026806-89B65D7B-C63E-456B-9563-C894837BE8F1Q27320687-8DBE342D-BE4A-4FC2-B0FF-5AF882705ED9Q27469855-13B4D1D2-8590-403B-8257-20B69861127BQ27485578-CF2727B9-68AE-4E1A-AD44-98668BB6973FQ27488806-9D173F58-E26B-48F7-B3CE-8D3DA8C1A24AQ27489000-B2B8B464-8D75-4DBD-BDC5-6FC43ABE0AE2Q27637675-D4F2FE8B-BD2B-42A4-A30B-E1BD82553864Q27643993-72D552AE-AC9D-4F80-A33C-413E4006EE19Q27644383-6D9F10A7-53B0-41BB-974A-75FE8F8F6EACQ27655865-8C0F3E37-55DF-42DD-B9E0-2980CD606FC6Q27658449-D3B06BC4-8F13-48BE-8FE8-F7DAEFBA2CEBQ27661588-ED76782D-8B0A-4639-A4C5-12479463230EQ27662155-2F3C390C-DCD4-47DE-9448-2B772E240D69Q27662167-E653557A-BFE6-4BF5-B157-767E01C902A5Q27665884-6928CA7A-36BF-4136-A6B8-5FBCF0277175Q27671696-C3931BBC-D4A1-4BC6-B963-641C5B54AB77Q27675131-2984110A-9FA9-414C-84D9-FB975CB108BAQ27675190-11D1E520-A7A6-4386-BD3C-6E6EB0682D5AQ27680704-18133AEF-F447-4C2E-A702-A95A99D3210EQ27683553-DD84CE2E-F55E-40D8-A4F7-892044006EAEQ28066335-53F6562E-4A4F-4E39-A1E2-095F8149C887Q28068018-1602B4AD-663C-4DC3-9F83-F41F5E222E24Q28075274-45F0259B-C9C6-4FA1-9128-72291C6DF190
P2860
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Efficient neutralization of pr ...... nant human monoclonal antibody
@ast
Efficient neutralization of pr ...... nant human monoclonal antibody
@en
type
label
Efficient neutralization of pr ...... nant human monoclonal antibody
@ast
Efficient neutralization of pr ...... nant human monoclonal antibody
@en
prefLabel
Efficient neutralization of pr ...... nant human monoclonal antibody
@ast
Efficient neutralization of pr ...... nant human monoclonal antibody
@en
P2093
P3181
P356
P1433
P1476
Efficient neutralization of pr ...... nant human monoclonal antibody
@en
P2093
Thornton GB
P304
P3181
P356
10.1126/SCIENCE.7973652
P407
P577
1994-11-11T00:00:00Z